Kewajiban Lancar Perubahan Tanggal
Akebia Therapeutics USD 162.35M 1.48M 2026-09
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Celltrion KRW 288.01B 4.7B 2026-06
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 28.51M 5.87M 2026-09
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Gilead Sciences USD 12B 982M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Kangmei Pharma CNY 5.1B 280.48M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
MacroGenics USD 108.82M 12.88M 2026-06
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 107.28M 18.54M 2026-06
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pfizer USD 31.73B 920M 2026-09
Pharma Mar EUR 125.39M 26.97M 2026-09
Qiagen NV USD 581.45M 102.34M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 29.77B 2.16B 2026-09
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Sartorius EUR 1.55B 102.8M 2026-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Takeda JPY 2.6T 161B 2026-09
Tilray USD 259.32M 8.32M 2025-09
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.74B 277.02M 2026-09